Showing results 4 to 8 of 8
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Correlation of Src activation with response to dasatinib, capecitabine, oxaliplatin, and bevacizumab in advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology | 2013 | ||
Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing Journal:Clinical Cancer Research | 2015 | ||
A leave-one-out cross-validation SAS macro for the identification of markers associated with survival Journal:Computers in Biology and Medicine | 2015 | ||
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105 Journal:Molecular Cancer Therapeutics | 2018 | ||
2014 |